Skip to main content
Journal for Immunotherapy of Cancer logoLink to Journal for Immunotherapy of Cancer
. 2022 Nov 3;10(11):e003783corr1. doi: 10.1136/jitc-2021-003783corr1

Correction: First report of CART treatment in AL Amyloidosis and relapsed/refractory multiple myeloma

PMCID: PMC9639122  PMID: 36328380

Oliver-Caldes A, Jiménez R, Español-Rego M, et al. First report of CART treatment in AL amyloidosis and relapsed/refractory multiple myeloma. J Immunother Cancer 2021;9:e003783. doi: 10.1136/jitc-2021-003783

The funding statement has been updated to include the statement “This study has been funded by Instituto de Salud Carlos III through the project “ICI19/00025” (Co-funded by European Regional Development Fund “A way to make Europe”)”.


Articles from Journal for Immunotherapy of Cancer are provided here courtesy of BMJ Publishing Group

RESOURCES